Literature DB >> 23652773

The association between osteoporosis and hypertension: the role of a low dairy intake.

Massimo Varenna1, M Manara, L Galli, L Binelli, F Zucchi, L Sinigaglia.   

Abstract

Hypertension and related cardiovascular diseases are reported to be associated with osteoporosis. A nutritional pathway related to dairy intake has been postulated for both diseases. The aim of this study was to assess calcium intake from dairy sources as a possible pathogenic link between osteoporosis and hypertension. This was a cross-sectional observational study performed on 3,301 postmenopausal women referred for a densitometry screening. Osteoporosis was diagnosed by lumbar dual-energy X-ray absorptiometry and hypertension was defined by blood pressure data and/or the use of antihypertensive medication. Dairy food consumption was evaluated using a weekly food-frequency questionnaire. The odds of being affected by osteoporosis, hypertension, or both diseases were calculated for quartiles of dairy intake by logistic regression analyses. Women with hypertension were affected more frequently by osteoporosis (33.2 vs. 23.3 %; p = 0.000), and there was a higher prevalence of hypertension among women with osteoporosis (32.2 vs. 22.5 %; p = 0.000). The proportion of women with hypertension, osteoporosis, and both diseases significantly increased across decreasing quartiles of dairy intake. A dairy intake in the lowest quartile was a significant predictor of osteoporosis [OR (95 % CI): 1.43 (1.12, 1.82)] and hypertension [OR (95 % CI): 1.46 (1.15, 1.85)] when compared to the highest quartile. Similarly, a low dairy intake was associated with increased odds to have both the diseases [OR (95 % CI): 1.60 (1.10, 2.34)]. From these results we conclude that osteoporosis and hypertension are associated in postmenopausal women, and a low dairy intake may increase the risk of both diseases, acting as a possible pathogenic link.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652773     DOI: 10.1007/s00223-013-9731-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  16 in total

Review 1.  Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic Health.

Authors:  Kristin M Hirahatake; Richard S Bruno; Bradley W Bolling; Christopher Blesso; Lacy M Alexander; Sean H Adams
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

2.  Association between serum uric acid and lumbar spine bone mineral density in peri- and postmenopausal Japanese women.

Authors:  S Ishii; M Miyao; Y Mizuno; M Tanaka-Ishikawa; M Akishita; Y Ouchi
Journal:  Osteoporos Int       Date:  2013-12-07       Impact factor: 4.507

3.  Does Subjective Sleep Affect Bone Mineral Density in Older People with Minimal Health Disorders? The PROOF Cohort.

Authors:  Magali Saint Martin; Pierre Labeix; Martin Garet; Thierry Thomas; Jean-Claude Barthélémy; Philippe Collet; Frédéric Roche; Emilia Sforza
Journal:  J Clin Sleep Med       Date:  2016-11-15       Impact factor: 4.062

4.  The effect of calcium and vitamin D supplementation on osteoporotic rabbit bones studied by vibrational spectroscopy.

Authors:  Athina Lani; Nikolaos Kourkoumelis; Gerasimos Baliouskas; Margaret Tzaphlidou
Journal:  J Biol Phys       Date:  2014-07-09       Impact factor: 1.365

5.  Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity.

Authors:  Yuan-Yuei Chen; Wen-Hui Fang; Chung-Ching Wang; Tung-Wei Kao; Yaw-Wen Chang; Chen-Jung Wu; Yi-Chao Zhou; Yu-Shan Sun; Wei-Liang Chen
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

6.  Increased risk of benign paroxysmal positional vertigo in osteoporosis: a nationwide population-based cohort study.

Authors:  Hayoung Byun; Jae Ho Chung; Seung Hwan Lee; Chul Won Park; Eun Mi Kim; Inah Kim
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

7.  Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats.

Authors:  Gabriel Mulinari-Santos; Jaqueline Silva Dos Santos; Letícia Pitol Palin; Ana Cláudia Ervolino da Silva; Cristina Antoniali; Leonardo Perez Faverani; Roberta Okamoto
Journal:  J Appl Oral Sci       Date:  2019-10-07       Impact factor: 2.698

8.  Determining the association between hypertension and bone metabolism markers in osteoporotic patients.

Authors:  Zhuoqing Hu; Kevin Yang; Zhihui Hu; Miaosheng Li; Hao Wei; Zheng Tang; Baitong Chen; Chengbiao Su; Jinrong Xu
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

9.  Long-term effects of antihypertensive medications on bone mineral density in men older than 55 years.

Authors:  Kamil Serkan Ağaçayak; Sedat Güven; Mahmut Koparal; Nedim Güneş; Yusuf Atalay; Serhat Atılgan
Journal:  Clin Interv Aging       Date:  2014-03-27       Impact factor: 4.458

10.  Osteoporosis, vertebral fractures and metabolic syndrome in postmenopausal women.

Authors:  Abdellah El Maghraoui; Asmaa Rezqi; Salwa El Mrahi; Siham Sadni; Imad Ghozlani; Aziza Mounach
Journal:  BMC Endocr Disord       Date:  2014-12-10       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.